These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17368950)

  • 1. Biomarkers for early detection of breast cancer: what, when, and where?
    Levenson VV
    Biochim Biophys Acta; 2007 Jun; 1770(6):847-56. PubMed ID: 17368950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors.
    Abrao Nemeir I; Saab J; Hleihel W; Errachid A; Jafferzic-Renault N; Zine N
    Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31126047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.
    Mannello F; Ligi D
    BMC Cancer; 2013 Jul; 13():344. PubMed ID: 23849048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
    Tainsky MA
    Biochim Biophys Acta; 2009 Dec; 1796(2):176-93. PubMed ID: 19406210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer.
    Behl T; Kumar A; Vishakha ; Sehgal A; Singh S; Sharma N; Yadav S; Rashid S; Ali N; Ahmed AS; Vargas-De-La-Cruz C; Bungau SG; Khan H
    Int J Biol Macromol; 2023 Dec; 253(Pt 1):126595. PubMed ID: 37648139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework.
    Wang E; Henderson M; Yalamanchili P; Cueto J; Islam Z; Dharmani C; Salas M
    Biomark Med; 2024; 18(6):265-277. PubMed ID: 38487948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting-edge innovations in breast cancer diagnosis- the potential of HDMI biomarkers.
    Zahra K; Farooqi HA
    Clin Exp Metastasis; 2024 Feb; 41(1):77-78. PubMed ID: 37847349
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in ER and HER2 testing by IHC in breast cancer.
    Gown AM
    Mod Pathol; 2008 May; 21 Suppl 2():S8-S15. PubMed ID: 18437174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen-Printed Electrodes as Low-Cost Sensors for Breast Cancer Biomarker Detection.
    Shen Y; Sun Z; Zhao S; Chen F; Shi P; Zhao N; Sun K; Ye C; Lin C; Fu L
    Sensors (Basel); 2024 Aug; 24(17):. PubMed ID: 39275589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-Based DNA Methylation Analysis by Multiplexed OBBPA-ddPCR to Verify Indications for Prostate Biopsies in Suspected Prostate Cancer Patients.
    Friedemann M; Jandeck C; Tautz L; Gutewort K; von Rein L; Sukocheva O; Fuessel S; Menschikowski M
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of breast density in women aged 18 years and older.
    Perera D; Pirikahu S; Walter J; Cadby G; Darcey E; Lloyd R; Hickey M; Saunders C; Hackmann M; Sampson DD; Shepherd J; Lilge L; Stone J
    Breast Cancer Res Treat; 2024 Jun; 205(3):521-531. PubMed ID: 38498102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretome analysis of breast cancer cells to identify potential target proteins of
    Swami S; Mughees M; Mangangcha IR; Kauser S; Wajid S
    Front Cell Dev Biol; 2023; 11():1247632. PubMed ID: 37900279
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer.
    Ye Q; Wang J; Ducatman B; Raese RA; Rogers JL; Wan YW; Dong C; Padden L; Pugacheva EN; Qian Y; Guo NL
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression.
    Robinson K; Cao Z; Delfino K; Cao D; Rao K
    J Int Med Res; 2023 Jun; 51(6):3000605231179317. PubMed ID: 37389562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid crystal-assisted optical biosensor for early-stage diagnosis of mammary glands using HER-2.
    Pourasl MH; Vahedi A; Tajalli H; Khalilzadeh B; Bayat F
    Sci Rep; 2023 Apr; 13(1):6847. PubMed ID: 37100835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Electrochemical Immunosensors for HER-1 and HER-2 Analysis in Serum for Breast Cancer Patients.
    Wignarajah S; Chianella I; Tothill IE
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of DNA Methylation and Gene Expression Identified Follicular Thyroid Cancer-Specific Diagnostic Biomarkers.
    Yao Y; Xu P; Ying T; Wang Y; Wang X; Shu L; Mo Z; Chen Z; Wang X; Wang W; Teng L; Lou X
    Front Endocrinol (Lausanne); 2021; 12():736068. PubMed ID: 35370931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study.
    Cao Z; Delfino K; Tiwari V; Wang X; Hannan A; Zaidi F; McClintock A; Robinson K; Zhu Y; Gao J; Cao D; Rao K
    Front Oncol; 2022; 12():727505. PubMed ID: 35280770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications.
    Afzal S; Hassan M; Ullah S; Abbas H; Tawakkal F; Khan MA
    Front Mol Biosci; 2022; 9():783450. PubMed ID: 35265667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.